Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Elevation Oncology, Inc. | CHIEF SCIENTIFIC OFFICER | Restricted Stock Unit | 37.5K | $19.1K | $0.51 | Feb 15, 2024 | Direct |
Elevation Oncology, Inc. | CHIEF SCIENTIFIC OFFICER | Stock Option (Right to Buy) | 225K | Feb 15, 2024 | Direct | ||
Bolt Biotherapeutics, Inc. | Chief Scientific Officer | Stock Option (Right to Buy) | 210K | Feb 18, 2022 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
ELEV | Elevation Oncology, Inc. | Feb 15, 2024 | 2 | $0 | 4 | Feb 20, 2024 | CHIEF SCIENTIFIC OFFICER |
ELEV | Elevation Oncology, Inc. | Feb 15, 2023 | 1 | $0 | 4 | Feb 17, 2023 | CHIEF SCIENTIFIC OFFICER |
ELEV | Elevation Oncology, Inc. | Jan 6, 2023 | 1 | $0 | 4 | Jan 10, 2023 | CHIEF SCIENTIFIC OFFICER |
ELEV | Elevation Oncology, Inc. | Mar 14, 2022 | 1 | $0 | 4 | Mar 16, 2022 | Chief Scientific Officer |
ELEV | Elevation Oncology, Inc. | Mar 14, 2022 | 0 | $0 | 3 | Mar 16, 2022 | Chief Scientific Officer |
BOLT | Bolt Biotherapeutics, Inc. | Feb 18, 2022 | 1 | $0 | 4 | Feb 23, 2022 | Chief Scientific Officer |